Cyprus’ Pharmaceutical Exports in 2025: Trade Overview

The statistical data of Cyprus’ pharmaceutical export industry show the considerable role the industry plays in the country’s international trade due to pharmaceutical production, medicine formulation and packaging, and the distribution of pharmaceuticals across European countries and worldwide markets. Cyprus, being a member of the European Union, conducts its activities in the regulated environment enforcing quality standards for the medicine produced, safety of trade goods, and compliance with the rules of pharmaceuticals manufacturing. The pharmaceutical goods are classified according to HS Chapter 30, which covers medicines, vaccinations, blood products, antibiotics, pharmaceutical preparations, and other kinds of medicines.

The international trade statistics of Cyprus for 2025 indicate that the value of pharmaceutical products exported from the country totalled about US$511.10 million. The main countries that receive pharmaceutical goods from Cyprus are Greece, Romania, France, the Czech Republic, and Vietnam. This list of countries shows the significance of the European distribution networks as well as the potential of Asian markets.

The effectiveness of Cyprus’ pharmaceutical export depends on the industry capacity, world demand for pharmaceutical products, availability of regulatory approvals, established distribution partnerships, and competition from global pharmaceutical companies. Those who need to analyse Cyprus Import Data can use Import Globals latest insights to stay updated with the trade information.

CYPRUS’ MAJOR EXPORT PRODUCTS IN THE PHARMACEUTICAL SECTOR IN 2025

Pharmaceutical products fall under the general classification of HS chapter 30. This chapter consists of finished medicines, vaccines, antibiotics, pharmaceutical ingredients, and medical dressings. The subsections below summarize some important categories of products that appear in the HS chapter, and an individual HS number valuation for every product is omitted in the export totals provided below.

Medicaments in Measured Doses or Retail Packaging — HS Code 3004

This category incorporates many finished medicines used for treating or preventing diseases, as retail formulations are key for pharmacies, hospitals, distributors, and state healthcare systems. The demand for retail medicines will depend on the need for treatment, availability of medicines, their regulatory approvals, and the strength of the distribution network, as per Cyprus Trade Statistics.

Medicaments with Antibiotics — HS Code 3003 and HS Code 3004 Antibiotics are used in the treatment of some bacterial diseases, which makes them a part of the supply chain of medicines that will be delivered to medical institutions. They could be classified based on the way they are packaged.

Vaccines, Blood Products and Immunological Products — HS Code 3002

Under this heading, vaccines and similar items are covered, including blood fractions. Different handling requirements, regulated documentation, and temperature-controlled logistics need to be applied for product transportation. Export activities depend on success in approvals, supply agreements, and the needs of healthcare systems.

Pharmaceutical Ingredients and Bulk Medicaments — HS Code 3003

This classification implies the import of medicaments not having any measurement or packaging. Such products can also be utilized in the formulation and packaging of the products. The composition and regulatory compliance become the main criteria for the buyer.

Wadding, Gauze, Bandages and Similar Pharmaceutical Goods — HS Code 3005

This classification includes separately exhibited medical products, designed for surgical or dental applications. The demand comes mainly from pharmacies, hospitals, and medical distributors. The product specification and reliability of delivery determine its competitiveness.

EXPORT MARKETS FOR PHARMACEUTICALS FROM CYPRUS IN 2025

The following economic indicators come from the reported figures for 2025 under HS chapter number 30. Market shares are calculated against the total value of approximately US$511.10 million.

Greece — US$67.87 million | 13.28% Share of Exports
 For the year 2025, Greece is identified as the largest market for pharmaceutical products from Cyprus. Close geographical location, trade ties and networks, and advanced logistics systems in both countries facilitate the exchange of goods between Cyprus and Greece. The strategic location of Greece makes it the main destination for all those Cyprus manufacturers that are looking for markets in the region.

Romania — US$54.20 million | 10.60% Share of Exports
 Romania is reported to be the second exporter of pharmaceutical products from Cyprus, reported Cyprus Shipments Data. The country, being a part of the European Union market, provides the favourable conditions for those suppliers that are trying to reach wholesalers, pharmacies and distributors of healthcare. However, the exporters of pharmaceutical products should fulfil all European standards related to the regulatory and documentation part of exporting products.

France — 47.83 million USD | Export share of 9.36%
 France is indeed the location where Cyprus was able to sell pharmaceutical products effectively. Greece’s well-established healthcare and distribution system can serve as a pathway to the larger market in Europe. Product registration, competitive pricing, and available supply chains are crucial for the successful operation in this country.

Czech Republic — 34.06 million USD | Export share of 6.66%
 The Czech Republic is also one of the most important Central European countries for Cyprus in terms of exports. Importers and distributors in this country can get access to products via local suppliers as it follows international rules. It is essential that exporters become familiar with the requirements of certain products, buying habits, and distribution networks of local pharmaceutical companies.

HOW DOES IMPORT GLOBALS ASSIST BUSINESSES IN THE PHARMACEUTICAL TRADE?
 The way in which Import Globals conducts its operations assists pharmaceutical businesses by making research on overseas markets possible through customs information, trade statistics, and other data concerned with shipments. For companies that need to obtain Cyprus Pharmaceutical Export Data, Import Globals provides valuable materials on market evaluation and buyer research.

Research into potential buyers: This type of analysis enables you to learn about potential pharmaceutical importers, distributors, wholesalers, and other buyers, depending on the specifics of the trade data available.

Export market research: Cyprus Export Data can help companies conduct research concerning export markets and observe export flows to make the decision on whether the particular markets are worth investigating further.

HS-code analysis: The HS classification system is helpful because it allows differentiating among finished medicaments classified under HS 3004, vaccines and biological preparations classified under HS 3002, and other products classified in Chapter 30.

Competition analysis: It is possible to acquire insights into suppliers’ activities, product descriptions, shipment modes, and destination markets through trade records.

Trend analysis: Companies can observe changes in trade values to see how markets change over time, how countries previously regarded as important perform, and how to form the export strategy.

PROSPECTS FOR PHARMACEUTICAL EXPORTS FROM CYPRUS

The prospects for the pharmaceutical exports of Cyprus will hinge on international medicine demand, production capacity, the number of products able to be registered, distribution ties, and the capacity of local manufacturers to face competition abroad. 
 
 At the same time, there are challenges to overcome in order to achieve success. First of all, pharmaceutical products should continue to meet various quality, safety, labelling, and registration requirements, while the country of destination imposes constraints on products coming from abroad.

CTA

Looking for the active trade information regarding the pharmaceuticals trade of Cyprus, then you have come to the right platform here. Import Globals helps businesses resolve trade complexities with active trade insights of the global marketplace. Subscribe to www.importglobals.com or drop an email at info@importglobals.com to get accurate information regarding the pharma trade to transform your international business growth.

FAQ’s

 Que — What is the export trade value of pharmaceuticals from Cyprus in 2025?
 Ans — The export trade value of pharmaceuticals from Cyprus in 2025 isUS$511.10 million.

Que — Who is the top export partner of pharmaceuticals for Cyprus in 2025?
 Ans — The top export partner of pharmaceuticals for Cyprus in 2025 is Greece.

Que — How does Cyprus’s import-export data support business
 growth?
 Ans — Cyprus’s import-export data supports business growth via proper identification of buyers and suppliers, analysis of market demand, and development of effective market expansion strategies.

Que — What information is available in Cyprus trade data?
 Ans — Cyprus trade data covers importer name, exporter name, shipment date, HS code, product details, quantity, pricing information, origin country, importing country, and port details.

Que — How frequently is the Cyprus trade data updated?
 Ans — Cyprus trade data is updated on a monthly basis.

Que — Where can you obtain detailed information on Cyprus
 trade data?
 Ans — Visit www.importglobals.com or drop an email at info@importglobals.com for detailed updates on Cyprus trade data.